Cargando…
Relationship between miR-7 expression and treatment outcomes with gefitinib in non-small cell lung cancer
The aim of the present study was to assess the effects of gefitinib chemotherapy on the serum levels of miR-7 in patients with non-small cell lung cancer (NSCLC). A total of 126 patients were enrolled in the present study (stage I–II, n=54 and stage III–IV, n=72). Patients with stage I–II NSCLC unde...
Autores principales: | Mou, Kun, Gu, Weiwei, Gu, Cuihua, Zhang, Jinzhong, Qwang, Wenjie, Ren, Gang, Tian, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228447/ https://www.ncbi.nlm.nih.gov/pubmed/28105168 http://dx.doi.org/10.3892/ol.2016.5290 |
Ejemplares similares
-
let-7 and miR-17 promote self-renewal and drive gefitinib resistance in non-small cell lung cancer
por: Yin, Jun, et al.
Publicado: (2019) -
miR-762 activation confers acquired resistance to gefitinib in non-small cell lung cancer
por: Ge, Peng, et al.
Publicado: (2019) -
Mechanism research of miR‐34a regulates Axl in non‐small‐cell lung cancer with gefitinib‐acquired resistance
por: Xiong, Ran, et al.
Publicado: (2019) -
miR-135a Confers Resistance to Gefitinib in Non-Small Cell Lung Cancer Cells by Upregulation of RAC1
por: Zhang, Tingting, et al.
Publicado: (2018) -
miR-196a Upregulation Contributes to Gefitinib Resistance through Inhibiting GLTP Expression
por: Liu, Bing-Jie, et al.
Publicado: (2022)